(Bloomberg) -- Theranos Inc., the health startup that performs many routine tests with only a fingerprick’s worth of blood, plans to announce for the first time that it will become the preferred lab-work provider for a health insurer.

Capital BlueCross, a Pennsylvania insurer that covers 725,000 consumers, will promote the California company’s tests. Theranos also will open new blood-work locations, called “wellness centers,” on the East Coast for the first time, Chief Executive Officer Elizabeth Holmes said.

Register or login for access to this item and much more

All Digital Insurance content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access